PREDICTED PRIMARY AND ANTIGENIC STRUCTURE OF CANINE CORTICOTROPIN-RELEASING HORMONE

被引:4
作者
MOL, JA [1 ]
VANWOLFEREN, M [1 ]
KWANT, I [1 ]
MELOEN, R [1 ]
机构
[1] DLO,CDI,LELYSTAD,NETHERLANDS
关键词
D O I
10.1016/0143-4179(94)90010-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the dog has been recognized as a useful model for the study of the cerebrospinal and peripheral actions of corticotropin releasing hormone (CRH) the exact amino acid composition of canine CRH is still unknown. In the present study the structure of canine CRH was predicted from the partial sequence of the gene encoding canine CRH. The CRH gene was amplified from genomic DNA obtained from white blood cells by a polymerase chain reaction and subsequently sequenced using the dideoxy method. The likely structure of canine CRH is: SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2, which is identical to the structure of human, rat and equine CRH. PEPSCAN analysis of 3 different CRH antisera predicted an antiserum raised against a conjugate of human CRH and CNBr -activated thyroglobulin to be the antiserum of choice for the measurement of CRH in the dog. Preliminary data confirmed the existence of the highest cross-reactivity of a canine hypothalamus extract, known to have a high content of CRH, with antisera directed against human, rat CRH. As a result of the present study immunological tools for CRH estimations are characterized. Also, a homologous DNA probe for in situ hybridizations has become available for further investigations.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 26 条
[1]   CORTICOTROPIN-RELEASING HORMONE (CRH) DIRECTLY STIMULATES CORTICOSTERONE SECRETION BY THE RAT ADRENAL-GLAND [J].
ANDREIS, PG ;
NERI, G ;
NUSSDORFER, GG .
ENDOCRINOLOGY, 1991, 128 (02) :1198-1200
[3]   OSMOREGULATION OF SYSTEMIC VASOPRESSIN RELEASE DURING LONG-TERM GLUCOCORTICOID EXCESS - A STUDY IN DOGS WITH HYPERADRENOCORTICISM [J].
BIEWENGA, WJ ;
RIJNBERK, A ;
MOL, JA .
ACTA ENDOCRINOLOGICA, 1991, 124 (05) :583-588
[4]   CORTICOTROPIN-RELEASING FACTOR IN THE DOG ADRENAL-MEDULLA IS SECRETED IN RESPONSE TO HEMORRHAGE [J].
BRUHN, TO ;
ENGELAND, WC ;
ANTHONY, ELP ;
GANN, DS ;
JACKSON, IMD .
ENDOCRINOLOGY, 1987, 120 (01) :25-33
[5]   DISTRIBUTION OF CORTICOTROPIN-RELEASING FACTOR-LIKE IMMUNOREACTIVITY IN HUMAN-BRAIN [J].
CHARLTON, BG ;
FERRIER, IN ;
PERRY, RH .
NEUROPEPTIDES, 1987, 10 (04) :329-334
[6]   PHYSIOLOGICAL AND BEHAVIORAL-RESPONSES TO CORTICOTROPIN-RELEASING FACTOR ADMINISTRATION - IS CRF A MEDIATOR OF ANXIETY OR STRESS RESPONSES [J].
DUNN, AJ ;
BERRIDGE, CW .
BRAIN RESEARCH REVIEWS, 1990, 15 (02) :71-100
[8]   CORTICOTROPIN-RELEASING FACTOR ACTS CENTRALLY TO SUPPRESS STIMULATED GASTRIC CONTRACTILITY IN THE RAT [J].
GARRICK, T ;
VEISEH, A ;
SIERRA, A ;
WEINER, H ;
TACHE, Y .
REGULATORY PEPTIDES, 1988, 21 (1-2) :173-181
[9]   CHARACTERIZATION OF RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR BY REVERSED-PHASE, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH SYNTHETIC OVINE CORTICOTROPIN-RELEASING FACTOR AS A MARKER [J].
HASHIMOTO, K ;
MURAKAMI, K ;
OHNO, N ;
KAGEYAMA, J ;
HATTORI, T ;
AOKI, Y ;
TAKAHARA, J .
NEUROENDOCRINOLOGY, 1983, 36 (04) :272-276
[10]   DEXAMETHASONE DOES NOT SUPPRESS THE RESPIRATORY ANALEPTIC EFFECT OF CORTICOTROPIN-RELEASING HORMONE [J].
HUBER, I ;
KRAUSE, U ;
NINK, M ;
LEHNERT, H ;
BEYER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (02) :440-442